• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Proscia Introduces First Cloud-Based Software Platform for Digital Pathology (Interview)

May 1st, 2015 Michael Batista Exclusive, News, Pathology

ProsciaFounded in 2014 by technologists from Johns Hopkins, the Moffitt Cancer Center, The Ohio State University College of Medicine, and the University of Pittsburgh, Proscia is a digital healthcare company with a mission to bring image analysis and big data capabilities to pathology. Proscia’s main focus area is fighting cancer. The company’s vision is to bring computer intelligence to pathology—to organize the world’s pathology information and put it to use fighting cancer. Image analysis and machine-learning technologies in the company’s technology pipeline will allow for unprecedented big data informatics in the industry.

On March 25, Proscia announced the launch of its first-generation software platform. This initial product release provides multi-gigabyte digital biopsy cloud-based storage and leverages the company’s second-opinion collaboration technology.

The Proscia platform employs several key technologies to access, analyze, and share whole slide images with unprecedented speed, accuracy, and quality. “There are tens of millions of biopsies performed annually, analyzed solely by the human eye,” stated David West Jr., Proscia president and CEO. “This is archaic. We built a modern, computing platform that will revolutionize the 150-year-old pathology workflow. Our software can discover and process millions of critical data points that will help pathologists and healthcare providers to diagnose, treat and ultimately prevent cancer.” Proscia’s patent-pending technologies combine multi-tenant cloud computing, image analysis, and machine learning with proprietary algorithms to bring unprecedented computer intelligence to the pathology field.

Key features of the Proscia platform that allow users to drastically improve whole slide image workflows include:

  • Secure storage, annotation and collaboration on multi-gigabyte digital biopsies
  • High resolution, deep zoom viewing
  • Support for all leading whole slide scan formats, as well as static images including Leica Biosystems (Aperio) .svs, .scn, and .tif, Phillips Digital Pathology .tiff, and Roche’s Ventana .bif.
  • Seamless integration with third-party storage services, including Dropbox, AWS, and in-house storage systems.
  • Enhanced Dropbox integration that enables multi-terabyte image migration to the Proscia platform in seconds
  • Tissue Microarray (TMA) functionality
  • No cost sign up and use of the Proscia for free up to 20GB of storage.

Following Proscia’s public announcement back in March, Medgadget had a chance to sit down for a short Q&A with Proscia President and CEO, David West, Jr.

Michael Batista, Medgadget: Where did the idea for Proscia come from?

David-West-ProsciaDavid West, Jr.: The underlying idea that became Proscia began as a project for image analysis using computers to look at biases and quantify those biases. The results we were getting were really very good so we started to explore the image analysis space and found a lot of interest. Even at this early stage we began to realize that what we were doing was bigger than just looking at a biopsy, by taking samples on slides and turning them into digital images, this was something that could revolutionize medicine.

 

Medgadget: When did this stop becoming a project and start looking like a company?

West: During the Spring of 2014, a few things came together with what we were working on that made us realize there was an opportunity here but, more importantly, the team came together. I met William, our Innovation Lead, in San Diego. He was studying computer science at Stanford and working in this space doing some great work. We realized we could team up to tackle this thing together. Around the same time I brought on Coleman, who I’d known for a long time and was studying computer science at the University of Pittsburgh, as our CTO, and Peeyush, from Ohio State’s biomedical science program, as our CSO.

 

Medgadget: What cancers are you going after and why?

West: Prostate, breast, and skin cancer. Prostate and breast cancer are some of the most common cancers and represent the leading cause of death both within and outside the US. Personally, my mother was diagnosed with breast cancer about 15 years ago, so it was always something I was interested in learning more about. Skin cancer, while not the most deadly form of cancer, has so many samples out there that it represents a ton of data for us to look at and represents a huge percentage of the pathology workflow.

 

Medgadget: Describe what happens today and how Proscia disrupts/improves on the current model?

West: Right now, pathologists look at biopsy slides and visually try to evaluate the tissue sample. The model is old and error-prone. Our approach is to digitize the images then run an analysis on the digital images providing immediate feedback to the pathologist with more information and insight than they would have been able to perceive with their eye alone.

Communication is also an important part of the platform since even today, pathologists will check with each other to get a second opinion on a biopsy sample. Today, the state of the art is to put an image on a file sharing system like Dropbox, which may or may not be compatible with the other pathologist’s viewer screen. On the Proscia cloud-based platform, you press a button, and the images are immediately viewable anywhere. Through the platform, we’re allowing the kind of communication and collaboration that occurs locally today to be universal.

 

Medgadget: Where is the platform now and where is it going?

West: The platform began with the ability to move digital biopsy content into a network environment to communicate with other pathologists along with a set of tools. This was where we started, the baseline. We ended up building the analysis part of the platform almost as a side effect. Recognizing what was happening, we took a step back, focused on the analysis, and are now releasing this as part of the platform. Today, anyone can log on and try out the platform. You can upload thousands of biopsies into the platform that anyone in the world with the right permissions can access. The entire platform is secure and HIPAA compliant.

From our users, we hear that the platform creates an incredibly fluid workflow compared to what happens today with tools that make everything extremely easy, intuitive, and sleek.

Moving forward, we are planning on adding on more tools to make workflow even faster and provide greater analytical insight. We have a lot in the pipeline so stay tuned a pathology platform that’s incredibly robust and incredibly efficient.

divider

Link: Proscia homepage…

Michael Batista

Michael Batista is a Baltimore-based editor motivated by disruptive innovation at the intersection of technology and healthcare. He holds a dual B.S. in materials and bioengineering from MIT and an M.S. in biomedical engineering from Johns Hopkins. Michael is currently Director of Healthworx, CareFirst BCBS' corporate development, and commercialization team. Michael is the former CEO of digital health startup Quantified Care through its exit to CollabCare and runs a board game publishing company.

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email